PROPERTIES OF INVITRO NONENZYMATICALLY GLYCATED PLASMA FIBRINOGENS

被引:12
作者
KRANTZ, S [1 ]
LOBER, M [1 ]
THIELE, M [1 ]
TEUSCHER, E [1 ]
机构
[1] ERNST MORITZ ARNDT UNIV, DEPT PHARM, DDR-2200 GREIFSWALD, GERMANY
来源
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY | 1987年 / 90卷 / 01期
关键词
D O I
10.1055/s-0029-1210670
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:37 / 45
页数:9
相关论文
共 24 条
[1]
FIBRINOCOAGULOPATHY IN MATURITY ONSET DIABETES-MELLITUS AND ATHEROSCLEROSIS [J].
BANERJEE, RN ;
SAHNI, AL ;
KUMAR, V .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1973, 30 (01) :123-132
[2]
THE BIOCHEMISTRY OF THE COMPLICATIONS OF DIABETES-MELLITUS [J].
BROWNLEE, M ;
CERAMI, A .
ANNUAL REVIEW OF BIOCHEMISTRY, 1981, 50 :385-432
[3]
NONENZYMATIC GLYCOSYLATION AND THE PATHOGENESIS OF DIABETIC COMPLICATIONS [J].
BROWNLEE, M ;
VLASSARA, H ;
CERAMI, A .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) :527-537
[4]
NON-ENZYMATIC GLYCOSYLATION REDUCES THE SUSCEPTIBILITY OF FIBRIN TO DEGRADATION BY PLASMIN [J].
BROWNLEE, M ;
VLASSARA, H ;
CERAMI, A .
DIABETES, 1983, 32 (07) :680-684
[5]
INHIBITION OF HEPARIN-CATALYZED HUMAN ANTITHROMBIN III ACTIVITY BY NONENZYMATIC GLYCOSYLATION - POSSIBLE ROLE IN FIBRIN DEPOSITION IN DIABETES [J].
BROWNLEE, M ;
VLASSARA, H ;
CERAMI, A .
DIABETES, 1984, 33 (06) :532-535
[6]
COPLEY AL, 1983, THROMB RES, P1
[7]
AFFINITY OF FIBRONECTIN TO COLLAGENS OF DIFFERENT GENETIC TYPES AND TO FIBRINOGEN [J].
ENGVALL, E ;
RUOSLAHTI, E ;
MILLER, EJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 147 (06) :1584-1595
[8]
HALLE W, 1980, ACTA BIOL MED GER, V39, P1165
[9]
REDUCED FIBRINOGEN SURVIVAL IN DIABETES-MELLITUS - REVERSIBLE PHENOMENON [J].
JONES, RL ;
PETERSON, CM .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 63 (03) :485-493
[10]
KAZAL LA, 1963, P SOC EXP BIOL MED, V113, P989